Asian Fund for Cancer Research (AFCR) shared on X
“The symposium at BIOHK2024 is starting out strong with welcoming remarks by our CEO, Dr. Sujuan Ba, and board member, Dr. Michael Yang. Immediately following the welcome remarks came Dr. Kucherlapati to discuss precision medicine in drug development.”
Source: AFCR/X
More posts featuring CityU-AFCR Symposium on oncodaily.com
